Sage Private Wealth Group, LLC Novo Nordisk A S Transaction History

Sage Private Wealth Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Jan 29, 2025	SELL	$119.07 - $145.42 $209,205 - $255,502	-1,757 Closed	0 $0
Q2 2024 Jan 29, 2025	SELL	$122.71 - $146.91 $368 - $440	-3 Reduced 0.17%	1,757 $250,000
Q1 2024 Jan 29, 2025	BUY	$102.11 - $135.92 $179,713 - $239,219	1,760 New	1,760 $225,000
Q2 2022 Aug 01, 2022	BUY	$103.24 - $121.81 $6,297 - $7,430	61 Added 6.39%	1,016 $113,000
Q1 2022 May 13, 2022	BUY	$93.1 - $112.54 $8,751 - $10,578	94 Added 10.92%	955 $106,000
Q4 2021 Jan 24, 2022	BUY	$95.88 - $117.08 $287 - $351	3 Added 0.35%	861 $96,000
Q4 2020 Mar 02, 2021	BUY	$63.89 - $73.8 $54,817 - $63,320	858 New	858 $60,000

1,882

336M

11.9M

10.6M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $204B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Sage Private Wealth Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Sage Private Wealth Group, LLC with notifications on news.